Immunosuppressant medication may be cost-effective for dry eye syndrome

A topical eye emulsion consisting of cyclosporine (a medication used to reduce transplant rejections or to treat arthritis and psoriasis) may be a cost-effective treatment for dry eye syndrome that does not respond to other therapies, according to a report in the February issue of Archives of Ophthalmology.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news153419053.html">Immunosuppressant medication may be cost-effective for dry eye syndrome</a></p> <p>A topical eye emulsion consisting of cyclosporine (a medication used to reduce transplant rejections or to treat arthritis and psoriasis) may be a cost-effective treatment for dry eye syndrome that does not respond to other therapies, according to a report in the February issue of <I>Archives of Ophthalmology</I>.</p>